Date: October 13, 2020
Time: 12:00 PM EDT
Duration: 30 Minutes
In our webinar, Understanding Rabies Prevention: Why HRIG Volume Matters where we take an in-depth look at some of the recent changes in the human rabies immune globulin (HRIG) market as well as provide educational information about rabies and rabies post-exposure prophylaxis (PEP).
The webinar covers the following key areas:
Current Roles
Previous Roles
Dr. Siegel is compensated by Kedrion Biopharma for his involvement in this program.
Current Roles
Previous Roles
Required *
Terms and Conditions: Kedrion Biopharma Inc. (“Kedrion Biopharma”) respects the privacy of your personal information. Kedrion Biopharma, and companies providing services to Kedrion Biopharma, may use the information that you provide to send you marketing or informational materials, analyze and use your information to improve or develop services and programs, and contact you about marketing programs or research about health topics that may be of interest to you.
Kedrion Biopharma, and companies providing services to Kedrion Biopharma, will not sell or rent your personally identifiable information. For more information regarding our Privacy Policy, click here.
References: 1. Scott TP, Nel LH. Subversion of the immune response by rabies virus. Viruses. 2016;8(8):E231. 2. Fooks AR, Banyard AC, Horton DL, Johnson N, McElhinney LM, Jackson AC. Current status of rabies and prospects for elimination. Lancet. 2014;384:1389-1399.